title: Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.
authors.forename: D
authors.initials: D
authors.lastname: Mattei
authors.forename: M
authors.initials: M
authors.lastname: Feola
authors.forename: F
authors.initials: F
authors.lastname: Orzan
authors.forename: N
authors.initials: N
authors.lastname: Mordini
authors.forename: D
authors.initials: D
authors.lastname: Rapezzi
authors.forename: A
authors.initials: A
authors.lastname: Gallamini
mesh_terms: D000069439:Dasatinib; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D015466:Leukemia, Myeloid, Chronic-Phase / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*; D014184:Transplantation, Homologous; D018497:Ventricular Dysfunction, Right / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib